| Website | oxyrane.com |
| Category | BioTech |
| Phone | +44 (0) 161 227 8887 |
| info@oxyrane.com | |
| Employees |
| TOTAL | $26.5M |
| FUNDING TOTAL | $26.5M |
| Series D, 11/11 Forbion Capital Partners Morningside Group New Science Ventures | $26.5M |
Oxyrane UK Limited is a biopharmaceutical company dedicated to the development of novel and biosuperior enzyme replacement therapies (ERT) to treat lysosomal storage diseases, a class of more than 40 rare, inherited diseases. Founded in 2006, the Company is headquartered in Manchester, United Kingdom with research facilities in Ghent, Belgium.
